Latest news articles

Added 5 days ago Drug news

FDA approves Twirla weekly application contraceptive patch.-Agile Therapeutics

Agile Therapeutics, Inc., a women’s healthcare company, announced that the FDA has approved Twirla (levonorgestrel and ethinyl estradiol) transdermal system....

Added 2 months ago Drug news

Amphora refiled with FDA for the prevention of pregnancy- Evofem Biosciences

Evofem Biosciences announced that it has resubmitted its New Drug Application (NDA) to the FDA for Amphora (L-lactic acid, citric...

Added 3 months ago Drug news

FDA extends PDUFA date for Twirla, a combined hormonal contraceptive patch, to 16 February 2020.- Agile Therapeutics

Agile Therapeutics, Inc. has announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date for...

Search all news articles for Contraceptive and procreative management

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.

Load more


Long-acting reversible contraception

This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.

Added 14 years ago

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Clinical Practice Guideline for the diagnosis, staging, risk assessment, and treatment of different cancer types during pregnancy; obstetric care and fetal follow-up; pregnancy in cancer survivors; and fertility preservation...

Added 6 years ago

Search all guidelines for Contraceptive and procreative management

Journal articles

Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low dose combined oral contraceptive.

Objectives: Safe and effective contraceptive options for obese women are becoming more important due to the obesity epidemic within the...

Added 4 years ago

Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.

OBJECTIVE: To assess 3-year data on the efficacy and safety of a new 52-mg levonorgestrel intrauterine contraceptive (LNG20) designed for...

Added 4 years ago

The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy

Background: Oral contraception (OC) and postmenopausal hormone therapy (HT) can be used to alleviate menopausal symptoms. However, the risk of venous...

Added 7 years ago

Search all journal articles for Contraceptive and procreative management